| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2020 | Oct 6, 2020 | Arcutis Biotherapeutics, Inc. | Director | Buy | 100.0 | +496,000 | 10.61% | ✗ | $12.4M |
| Feb 3, 2020 | Feb 4, 2020 | Arcutis Biotherapeutics, Inc. | Director | Buy | 100.0 | +558,888 | 100.00% | ✗ | $9.5M |
| Mar 2, 2018 | Mar 6, 2018 | GLAUKOS Corp | Director | Sell | 15.0 | -836,500 | -36.45% | ✗ | $26.8M |
| Jan 30, 2018 | Jan 30, 2018 | Adicet Bio, Inc. | Director | Buy | 100.0 | +533,333 | 12.41% | ✗ | $8M |
| Aug 31, 2017 | Sep 5, 2017 | GLAUKOS Corp | Director | Sell | 15.0 | -580,200 | -9.62% | ✗ | $22.5M |
| Aug 15, 2017 | Aug 17, 2017 | GLAUKOS Corp | Director | Sell | 15.0 | -325,000 | -6.38% | ✗ | $12.3M |
| Mar 10, 2017 | Mar 14, 2017 | GLAUKOS Corp | Director | Sell | 15.0 | -382,538 | -4.91% | ✗ | $17.3M |
| Mar 3, 2017 | Mar 7, 2017 | GLAUKOS Corp | Director | Sell | 17.5 | -55,772 | -2.56% | ✗ | $2.6M |
| Aug 10, 2016 | Aug 12, 2016 | GLAUKOS Corp | Director | Sell | 16.3 | -292,938 | -4.17% | ✗ | $9.9M |
| Aug 3, 2016 | Aug 5, 2016 | GLAUKOS Corp | Director | Sell | 15.0 | -425,000 | -14.67% | ✗ | $13M |
| Jun 30, 2015 | Jun 30, 2015 | GLAUKOS Corp | Director | Sell | 40.0 | -11,734 | -0.40% | ✗ | $211.2K |